Assessing metastatic potential of patients' renal carcinoma on a chip: ONCOTRAP

Archive ouverte

Filhol, Odile | Cesana, Beatrice | Séraudie, Irinka | Pillet, Catherine | Lambert, Elisa | Kaal, Joris | Descotes, Jean-Luc | Migliorini, Elisa | Cochet, Claude

Edité par CCSD -

International audience. Clear cell Renal Cell Carcinoma (ccRCC) is one of the most prevalent kidney cancers, which is often asymptomatic and thus discovered at a metastatic state (mRCC). mRCC are highly heterogeneous tumors composed of subclonal populations that lead to poor treatment response rate. Several recent works explored the potential of ccRCC tumoroids culture derived from patients. Following the observation that ccRCC tumoroids can create their own niche by secreting extracellular matrix components, we developed the first scaffold-free tumoroid model of ccRCC tumors. This model enables to evaluate invasiveness of renal cancer cells in a 3D context toward a metastatic niche. Inserted into a chip named ONCOTRAP, these tumoroids provide also a robust preclinical test to study metastatic process.

Suggestions

Du même auteur

Development of a biomimetic bone on chip to study kidney cancer metastasis : ONCOTRAP

Archive ouverte | Lambert, Elisa | CCSD

International audience. The majority of the solid tumors generate metastasis in different organs like the bone. This late tumor stage is considered as a lethal disease as the patient prognosis is very poor and treat...

A new scaffold-free tumoroid model provides a robust preclinical tool to investigate invasion and drug response in Renal Cell Carcinoma

Archive ouverte | Séraudie, Irinka | CCSD

International audience. Clear cell Renal Cell Carcinoma (ccRCC) is one of the most prevalent kidney cancers, which is often asymptomatic and thus discovered at a metastatic state (mRCC). mRCC are highly heterogeneou...

Cooperative Blockade of CK2 and ATM Kinases Drives Apoptosis in VHL-Deficient Renal Carcinoma Cells through ROS Overproduction

Archive ouverte | Giacosa, Sofia | CCSD

International audience. Kinase-targeted agents demonstrate antitumor activity in advanced metastatic clear cell renal cell carcinoma (ccRCC), which remains largely incurable. Integration of genomic approaches throug...

Chargement des enrichissements...